Literature DB >> 2684839

Fasting plasma caffeine level in cirrhotic patients: relation to plasma levels of catecholamines and renin activity.

M Hasegawa1, S Yamada, C Hirayama.   

Abstract

Fasting plasma caffeine concentrations, plasma levels of catecholamines and plasma renin activity were measured in patients with cirrhosis and control patients without hepatic dysfunction. A careful dietary history showed no significant difference in caffeine consumption (mean +/- S.E.) among 46 cirrhotics (86 +/- 7 mg per day) vs. 34 control patients (91 +/- 8 mg per day). Fasting plasma caffeine concentrations, however, were significantly higher (7.68 +/- 1.42 micrograms per ml) in cirrhotics than in controls (1.01 +/- 0.20 micrograms per ml) (p less than 0.01). Fasting plasma caffeine concentrations in cirrhotics varied significantly with Child's criteria, namely Child's A patients (2.06 +/- 0.38 micrograms per ml); Child's B patients (6.92 +/- 1.86 micrograms per ml), and Child's C patients (17.70 +/- 3.65 micrograms per ml) (p less than 0.001). In 44 cirrhotics, fasting plasma caffeine concentrations were compared with plasma levels of catecholamines and plasma renin activity. Plasma epinephrine concentrations were normal; however, plasma norepinephrine concentrations were increased in six cirrhotics, and plasma renin activities were increased in 28 cirrhotics. After a 3-day caffeine abstinence, plasma caffeine concentration and renin activity were significantly decreased (p less than 0.01), and high plasma norepinephrine levels were also decreased in 12 cirrhotics. Plasma caffeine concentration, renin activity and norepinephrine level did not change in a control group of cirrhotics who continued to receive caffeine for 3 days (n = 6). After abstinence from caffeine, the decrease of fasting plasma caffeine concentration correlated well with the decrease of plasma renin activity (r = +0.746, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684839     DOI: 10.1002/hep.1840100614

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis.

Authors:  E H Forrest; I A Bouchier; P C Hayes
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

2.  Endocrine and hemodynamic changes during liver surgery in patients with compensated liver cirrhosis.

Authors:  K Maruyama; S Sakakura; K Nishimura; T Kurioka; R Horiguchi; M Muneyuki
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

3.  Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis.

Authors:  Fen Liu; Xiwei Wang; Gang Wu; Ling Chen; Peng Hu; Hong Ren; Huaidong Hu
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

4.  Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan.

Authors:  K Wakai; Y Kurozawa; A Shibata; Y Fujita; K Kotani; I Ogimoto; M Naito; K Nishio; H Suzuki; T Yoshimura; A Tamakoshi
Journal:  Br J Cancer       Date:  2007-07-17       Impact factor: 7.640

5.  Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan.

Authors:  Y Kurozawa; I Ogimoto; A Shibata; T Nose; T Yoshimura; H Suzuki; R Sakata; Y Fujita; S Ichikawa; N Iwai; A Tamakoshi
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.